Loss-of-function variants of genes were described as risk factors for AD, among them TREM2, the triggering activating receptor expressed on myeloid cells and CD33 linked to reduced β-amyloid protein phagocytosis by microglia [37,38]. This evidence concerns the gene TREM2 and Alzheimer disease.